| Assay Method Information | |
| | In Vitro Inhibition of SARS NSP14/NSP10 Exonuclease Activity |
| Description: | Commercially available 2-Hydroxyisoquinoline-1,3(2H,4H)-dione (CAS No: 6890-08-0), a well-known scaffold backbone used to develop human immunodeficiency virus (HIV) integrase activity, was selected for proof-of-principle in vitro efficacy studies of SARS-CoV2 NSP14/NSP10 exonuclease inhibition by FRET-based activity assay. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |